The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale

Introduction

Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it.

Current Challenges

Proper management of diabetes starts with consistent and accurate monitoring of glucose levels. Yet, most diagnosed diabetics do not monitor their blood sugar as often as prescribed because it is painful and inconvenient to do so.

This is clear evidence that the €16+ billion glucose monitors industry needs a change – the current methods are not good enough.

Our Solution

We have invented, patented, and productized a new technology category for extracting and analyzing blood sugar levels in a completely non-invasive way.

Funding Application

We are applying for the EIC blended finance to further miniaturize, optimize, and clinically prove this technology on a wider scale.

Potential Impact

The financing will turn our breakthrough scientific discovery into an end-user device that can potentially impact over 2 billion people by helping them prevent diabetes onset altogether.